BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28397878)

  • 1. A novel Time-resolved Fluoroimmunoassay for the quantitative detection of Antibodies against the Phospholipase A2 Receptor.
    Huang B; Wang L; Zhang Y; Zhang J; Zhang Q; Xiao H; Zhou B; Sun Z; Cao YN; Chen Y; Hu Z; Sheng H
    Sci Rep; 2017 Apr; 7():46096. PubMed ID: 28397878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel time-resolved fluoroimmunoassay based on magnetic microspheres method for detecting antibodies against the phospholipase A2 receptor.
    Li T; Wu Q; Yang X; Liu Y; Lin B; Zhou X; Wang Y; Qin Y; Wang B; Hu Z; He Q; Huang B
    Anal Methods; 2021 Jul; 13(27):3017-3023. PubMed ID: 34164636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy.
    Huang B; Zhang Y; Wang L; Xu W; Zhang J; Zhang Q; Sheng H; Hu Z
    Kidney Blood Press Res; 2019; 44(4):848-857. PubMed ID: 31242492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
    Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
    Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 receptor.
    Li T; Wu Q; Yang X; Zhang Y; Zhou X; Sheng H; Wang Y; Zhang Q; Liu X; Qin Y; Huang B; Wang L; He Q; Hu Z
    Clin Biochem; 2021 Oct; 96():49-55. PubMed ID: 34252448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: Clinical value assessment.
    Cheng G; Liu J; Gilbert A; Cao Y; An C; Lv Z; Wang C; Nie R; Zhang J; Liu Y; Xia M; Li S; Cai H; Li Y; Li Y; Qin X
    Clin Chim Acta; 2019 Mar; 490():135-141. PubMed ID: 30605630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application of homemade ELISA kit for anti-human phospholipase A2 receptor antibody].
    Huang L; Zhang D; Wang Y; Zhang Q; Liang W; Zhang Y; Xiong Z
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):743-751. PubMed ID: 29893082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.
    Hihara K; Iyoda M; Tachibana S; Iseri K; Saito T; Yamamoto Y; Suzuki T; Wada Y; Matsumoto K; Shibata T
    PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease.
    Wang Q; Dong ZY; Zhang WG; Liu XM; Qu YL; Duan SW; Huang MJ; Zhou JH; Chen P; Zhu HY; Zhang L; Sun XF; Cai GY; Chen XM
    Clin Chim Acta; 2020 Mar; 502():222-226. PubMed ID: 31730818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
    Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
    Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.
    Huang Y; Zhou J; Zhou K; Huang B; Xue J; Zhang X; Liu B; Zhang Z; Zhou L; Cai T; Zhang Y; Hu Z; Wang L; Liu X
    PeerJ; 2022; 10():e14193. PubMed ID: 36248712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
    Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
    Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy.
    Huang B; Zhang Y; Wang L; Wu Q; Li T; Zhang J; Zhang Q; Sheng H; Bao J; Hu Z
    Front Immunol; 2020; 11():837. PubMed ID: 32425952
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience.
    Porcelli B; Guarnieri A; Ferretti F; Garosi G; Terzuoli L; Cinci F; Tabucchi A; Tampoia M; Abbracciavento L; Villani C; Deleonardi G; Grondona AG; Mazzolini M; La Manna G; Santostefano M; Infantino M; Manfredi M; Spatoliatore G; Rosati A; Somma C; Bizzaro N
    J Nephrol; 2021 Apr; 34(2):573-579. PubMed ID: 33123964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
    Hu R; Xing G; Wu H; Zhang Z
    Diagn Pathol; 2016 Sep; 11(1):86. PubMed ID: 27624606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to M-type phospholipase A2 receptor (PLA
    Garcia-Vives E; Solé C; Moliné T; Alvarez-Rios AM; Vidal M; Agraz I; Ordi-Ros J; Cortés-Hernández J
    Lupus; 2019 Mar; 28(3):396-405. PubMed ID: 30760090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis.
    Ong L; Silvestrini R; Chapman J; Fulcher DA; Lin MW
    Pathology; 2016 Apr; 48(3):242-6. PubMed ID: 27020499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: The optimal cut-off value for Chinese patients.
    Liu Y; Li X; Ma C; Wang P; Liu J; Su H; Zhuo H; Kong X; Xu D; Xu D
    Clin Chim Acta; 2018 Jan; 476():9-14. PubMed ID: 29126817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy.
    Liu X; Xue J; Guo X; Ding Y; Zhang Y; Zhang X; Huang Y; Huang B; Hu Z; Lu G; Wang L
    J Healthc Eng; 2021; 2021():1521013. PubMed ID: 34512932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.